Nuvig Therapeutics
PrivateLast Round
Series B
Dec 5, 2024
Total Funding Raised
$208M
Company Overview
Nuvig Therapeutics is a biotechnology company that develops innovative immunomodulatory therapies to restore immune homeostasis and treat chronic inflammatory and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuvig Therapeutics Comparables
Compare Nuvig Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immunovant | 78% | |
| Dianthus Therapeutics | 76% | |
| Annexon Biosciences | 75% | |
Nuvig Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 5, 2024 | ||||
| Series A | May 11, 2022 |
Key People
Founding team and executive leadership
Nuvig Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aberdeen Group plc | Series B |
| Digitalis Ventures | Series A, Series B |
| RM Global Partners | Series B |
| abrdn Inc. | Series B |
| B Capital Group | Series B |
| TD Securities | Series B |
| Blue Owl Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Celia J.F. Lin, M.D. appointed as Chief Medical Officer.
- Sep 9, 2025
James Mackay appointed as Independent Board Chair.
Nuvig Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuvig Therapeutics's valuation, stock price, and market status.